Response to first-line erlotinib in a false EGFR mutation-negative patient with non-small-cell lung cancer: Make no assumptions

• المؤلفون الرئيسيون: Caixia Deng (مؤلف), Hu Luo (مؤلف), Xiangdong Zhou (مؤلف)
• التنسيق: كتاب
• منشور في: Open Journal of Cell and Protein Science - Peertechz Publications, 2018-10-01.
• الموضوعات: Case Report
• الوصول للمادة أونلاين: Connect to this object online.

<p>So far, in the advanced non-small cell lung cancer (NSCLC) with clear epidermal growth factor receptor (EGFR) gene status, the treatment remmendations has reached an agreement: for patients with EGFR mutation-positive, epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs)...